Capsaicin Patches In Knee Osteoarthritis In Obese Patients

NCT03153813 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2019-04-17

No results posted yet for this study

Summary

To assess the efficacy and safety of high concentration capsaicin patches in pain due to osteoarthritis (OA) of the knee in patients with obesity

Conditions

Interventions

DRUG

capsaicin 8% patches (Qutenza)

OTHER

Placebo patches

Sponsors & Collaborators

  • Nadine ATTAL

    lead OTHER

Principal Investigators

  • Claire Carette · Hospital Ambroise Pare Paris

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2017-12-31
Completion
2018-12-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03153813 on ClinicalTrials.gov